Real-time Kinase assays AssayQuant offers PhosphoSens real-time, kinetic enzyme activity assays with fluorogenic sensors, enabling rapid, high-quality data to de-risk target biology and accelerate lead candidate prioritization. This positions them as a strategic complement to pharma R&D teams seeking faster, more reliable readouts for kinases and phosphatases.

Extensive assay catalog With a catalog of over four hundred optimized assays and access to tens of thousands of substrate substrates, there are broad cross-sell opportunities for established customers and high-value upsell potential for diversification into additional kinases or phosphatases and novel assay development services.

End-to-end capability Besides assay kits, AssayQuant provides custom assay development, transfer, and screening/potency/profiling services, offering a turnkey solution that can reduce customers’ internal resource burden and shorten time to result.

Collaborative growth fit With modest employee size (11–50) and mid-market revenue in the tens of millions, the company’s capabilities align well with mid to large biotech and specialty pharma looking to augment internal screening programs without large procurement frictions.

Tech and reach Active online presence and marketing tech stack featuring AWS, HubSpot, and analytics tools, coupled with potential integration opportunities for partner ecosystems, suggesting scalable channels for outbound campaigns and content-driven lead generation.